BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang J, Al-suwayeh SA. Nanoparticles as delivery carriers for anticancer prodrugs. Expert Opinion on Drug Delivery 2012;9:657-69. [DOI: 10.1517/17425247.2012.679927] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Meng Y, Zou S, Jiang M, Xu X, Tang BZ, Zhang L. Dendritic nanotubes self-assembled from stiff polysaccharides as drug and probe carriers. J Mater Chem B 2017;5:2616-24. [DOI: 10.1039/c7tb00213k] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 4.2] [Reference Citation Analysis]
2 He L, Sun M, Cheng X, Xu Y, Lv X, Wang X, Tang R. pH/redox dual-sensitive platinum (IV)-based micelles with greatly enhanced antitumor effect for combination chemotherapy. J Colloid Interface Sci 2019;541:30-41. [PMID: 30682591 DOI: 10.1016/j.jcis.2019.01.076] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
3 Al Faraj A, Shaik AS, Al Sayed B, Halwani R, Al Jammaz I. Specific targeting and noninvasive imaging of breast cancer stem cells using single-walled carbon nanotubes as novel multimodality nanoprobes. Nanomedicine (Lond) 2016;11:31-46. [PMID: 26673059 DOI: 10.2217/nnm.15.182] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
4 Cai T, Chen Y, Wang Y, Wang H, Liu X, Jin Q, Agarwal S, Ji J. Functional 2-methylene-1,3-dioxepane terpolymer: a versatile platform to construct biodegradable polymeric prodrugs for intracellular drug delivery. Polym Chem 2014;5:4061-8. [DOI: 10.1039/c4py00259h] [Cited by in Crossref: 17] [Article Influence: 2.1] [Reference Citation Analysis]
5 Ding N, Wang Y, Wang X, Chu W, Yin T, Gou J, He H, Zhang Y, Wang Y, Tang X. Improving plasma stability and antitumor effect of gemcitabine via PEGylated liposome prepared by active drug loading. Journal of Drug Delivery Science and Technology 2020;57:101538. [DOI: 10.1016/j.jddst.2020.101538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Zhang R, Ru Y, Gao Y, Li J, Mao S. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer. Drug Des Devel Ther 2017;11:2631-42. [PMID: 28919713 DOI: 10.2147/DDDT.S143047] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
7 Luo C, Sun J, Sun B, He Z. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends Pharmacol Sci 2014;35:556-66. [PMID: 25441774 DOI: 10.1016/j.tips.2014.09.008] [Cited by in Crossref: 175] [Cited by in F6Publishing: 167] [Article Influence: 21.9] [Reference Citation Analysis]
8 Manatunga DC, de Silva RM, de Silva KN, de Silva N, Bhandari S, Yap YK, Costha NP. pH responsive controlled release of anti-cancer hydrophobic drugs from sodium alginate and hydroxyapatite bi-coated iron oxide nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 2017;117:29-38. [DOI: 10.1016/j.ejpb.2017.03.014] [Cited by in Crossref: 60] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
9 Chung SK, Shin GH, Jung MK, Hwang IC, Park HJ. Factors influencing the physicochemical characteristics of cationic polymer-coated liposomes prepared by high-pressure homogenization. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2014;454:8-15. [DOI: 10.1016/j.colsurfa.2014.03.095] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
10 Huang S, Huang G. The dextrans as vehicles for gene and drug delivery. Future Medicinal Chemistry 2019;11:1659-67. [DOI: 10.4155/fmc-2018-0586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
11 Carbone C, Leonardi A, Cupri S, Puglisi G, Pignatello R. Pharmaceutical and biomedical applications of lipid-based nanocarriers. Pharm Pat Anal 2014;3:199-215. [PMID: 24588596 DOI: 10.4155/ppa.13.79] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
12 Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release 2015;200:138-57. [PMID: 25545217 DOI: 10.1016/j.jconrel.2014.12.030] [Cited by in Crossref: 979] [Cited by in F6Publishing: 877] [Article Influence: 122.4] [Reference Citation Analysis]
13 Yang S, Sun IC, Hwang HS, Shim MK, Yoon HY, Kim K. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy. J Mater Chem B 2021;9:3983-4001. [PMID: 33909000 DOI: 10.1039/d1tb00397f] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Ashwanikumar N, Kumar NA, Asha Nair S, Vinod Kumar GS. 5-Fluorouracil-lipid conjugate: potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles. Acta Biomater 2014;10:4685-94. [PMID: 25110286 DOI: 10.1016/j.actbio.2014.07.032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
15 Aljuffali IA, Lin Y, Fang J. Noninvasive approach for enhancing small interfering RNA delivery percutaneously. Expert Opinion on Drug Delivery 2015;13:265-80. [DOI: 10.1517/17425247.2016.1121988] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rahimpour Y, Hamishehkar H, Nokhodchi A. Lipidic Micro- and Nano-Carriers for Pulmonary Drug Delivery-A State-of-the-Art Review. In: Nokhodchi A, Martin GP, editors. Pulmonary Drug Delivery. Chichester: John Wiley & Sons, Ltd; 2015. pp. 123-42. [DOI: 10.1002/9781118799536.ch6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Gu Y, Ma J, Fu Z, Xu Y, Gao B, Yao J, Xu W, Chu K, Chen J. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy. Int J Nanomedicine 2019;14:8805-18. [PMID: 31806973 DOI: 10.2147/IJN.S210938] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
18 Al Faraj A, Shaik AS, Halwani R, Alfuraih A. Magnetic Targeting and Delivery of Drug-Loaded SWCNTs Theranostic Nanoprobes to Lung Metastasis in Breast Cancer Animal Model: Noninvasive Monitoring Using Magnetic Resonance Imaging. Mol Imaging Biol 2016;18:315-24. [PMID: 26486793 DOI: 10.1007/s11307-015-0902-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
19 Xu C, He W, Lv Y, Qin C, Shen L, Yin L. Self-assembled nanoparticles from hyaluronic acid-paclitaxel prodrugs for direct cytosolic delivery and enhanced antitumor activity. Int J Pharm 2015;493:172-81. [PMID: 26232702 DOI: 10.1016/j.ijpharm.2015.07.069] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
20 Karra N, Nassar T, Ripin AN, Schwob O, Borlak J, Benita S. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model. Small 2013;9:4221-36. [PMID: 23873835 DOI: 10.1002/smll.201301417] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
21 Franiak-pietryga I, Ziemba B, Messmer B, Skowronska-krawczyk D. Dendrimers as Drug Nanocarriers: The Future of Gene Therapy and Targeted Therapies in Cancer. In: Simonescu CM, editor. Dendrimers - Fundamentals and Applications. InTech; 2018. [DOI: 10.5772/intechopen.75774] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
22 Assa F, Jafarizadeh-malmiri H, Ajamein H, Vaghari H, Anarjan N, Ahmadi O, Berenjian A. Chitosan magnetic nanoparticles for drug delivery systems. Critical Reviews in Biotechnology 2016;37:492-509. [DOI: 10.1080/07388551.2016.1185389] [Cited by in Crossref: 69] [Cited by in F6Publishing: 47] [Article Influence: 11.5] [Reference Citation Analysis]
23 Hu J, Wang J, Wang G, Yao Z, Dang X. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Int J Mol Med 2016;37:690-702. [PMID: 26782731 DOI: 10.3892/ijmm.2016.2458] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
24 Egorova KS, Gordeev EG, Ananikov VP. Biological Activity of Ionic Liquids and Their Application in Pharmaceutics and Medicine. Chem Rev 2017;117:7132-89. [PMID: 28125212 DOI: 10.1021/acs.chemrev.6b00562] [Cited by in Crossref: 679] [Cited by in F6Publishing: 406] [Article Influence: 135.8] [Reference Citation Analysis]
25 Aljuffali IA, Lin C, Chen C, Fang J. The codrug approach for facilitating drug delivery and bioactivity. Expert Opinion on Drug Delivery 2016;13:1311-25. [DOI: 10.1080/17425247.2016.1187598] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
26 Mura S, Bui DT, Couvreur P, Nicolas J. Lipid prodrug nanocarriers in cancer therapy. J Control Release 2015;208:25-41. [PMID: 25617724 DOI: 10.1016/j.jconrel.2015.01.021] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 9.3] [Reference Citation Analysis]
27 Menezes PDP, Andrade TA, Frank LA, de Souza EPBSS, Trindade GDGG, Trindade IAS, Serafini MR, Guterres SS, Araújo AAS. Advances of nanosystems containing cyclodextrins and their applications in pharmaceuticals. Int J Pharm 2019;559:312-28. [PMID: 30703500 DOI: 10.1016/j.ijpharm.2019.01.041] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
28 Madni A, Batool A, Noreen S, Maqbool I, Rehman F, Kashif PM, Tahir N, Raza A. Novel nanoparticulate systems for lung cancer therapy: an updated review. J Drug Target 2017;25:499-512. [PMID: 28151021 DOI: 10.1080/1061186X.2017.1289540] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
29 Duhem N, Danhier F, Pourcelle V, Schumers JM, Bertrand O, Leduff CS, Hoeppener S, Schubert US, Gohy JF, Marchand-Brynaert J, Préat V. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity. Bioconjug Chem 2014;25:72-81. [PMID: 24328289 DOI: 10.1021/bc400326y] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 7.4] [Reference Citation Analysis]
30 Mishra V, Jung S, Park JM, Jeong HM, Lee H. Triazole-Containing Hydrogels for Time-Dependent Sustained Drug Release. Macromol Rapid Commun 2014;35:442-6. [DOI: 10.1002/marc.201300585] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
31 Fattahi N, Shahbazi MA, Maleki A, Hamidi M, Ramazani A, Santos HA. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines. J Control Release 2020;326:556-98. [PMID: 32726650 DOI: 10.1016/j.jconrel.2020.07.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
32 Clas S, Sanchez RI, Nofsinger R. Chemistry-enabled drug delivery (prodrugs): recent progress and challenges. Drug Discovery Today 2014;19:79-87. [DOI: 10.1016/j.drudis.2013.08.014] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
33 Zhang Q, Vakili MR, Li X, Lavasanifar A, Le XC. Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells. Biomaterials 2014;35:7088-100. [DOI: 10.1016/j.biomaterials.2014.04.072] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
34 Sun B, Luo C, Cui W, Sun J, He Z. Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy. Journal of Controlled Release 2017;264:145-59. [DOI: 10.1016/j.jconrel.2017.08.034] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 12.2] [Reference Citation Analysis]
35 Hsieh P, Aljuffali IA, Fang C, Chang S, Fang J. Hydroquinone-salicylic acid conjugates as novel anti-melasma actives show superior skin targeting compared to the parent drugs. Journal of Dermatological Science 2014;76:120-31. [DOI: 10.1016/j.jdermsci.2014.08.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
36 Lin M, Hung C, Hsu C, Lin Z, Fang J. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency. Future Medicinal Chemistry 2019;11:2131-50. [DOI: 10.4155/fmc-2018-0388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]